421 results on '"Claggett, B"'
Search Results
2. Effect of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction treated with beta-blockers: the DELIVER trial
3. Effect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial
4. Predicting heart failure readmission and all-cause mortality in patients with acute heart failure: a simple predischarge risk score
5. Effect of dapagliflozin in patients in Asia with heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER
6. Standardized longitudinal strain curves stratified by age and sex in healthy individuals: The Copenhagen City Heart Study
7. Echocardiographic characterization of patients with supranormal ejection fraction: pooled core laboratory analysis of the TOPCAT and PARAGON-HF trials
8. Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial
9. Calcium channel blockade and survival in recipients of successful renal transplant: an analysis of the FAVORIT trial results
10. Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial
11. Increased circumferential deformation predicts cardiac events when left ventricular ejection fraction is normal
12. Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial
13. Atrial fibrillation in patients with high-risk acute myocardial infarction – the PARADISE-MI trial
14. Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: insight from PARADISE MI trial
15. PARADISE-MI – event rates and treatment effect of sacubitril/valsartan v ramipril by the presence or absence of transient pulmonary congestion and/or LVEF less or greater than 40
16. Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals
17. Proteomic biomarkers associated with incident heart failure and frailty in late life
18. A comprehensive study of the incremental prognostic value of novel biomarkers in PARADIGM-HF (Bio-PREDICT-HF)
19. Trajectory of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction and association with cardiac structure and function
20. Differing approaches to analyse on-treatment cardiovascular events comparing daprodustat with darbepoetin: results from the ASCEND-ND trial
21. Sex disaggregated analysis of risk factors for adverse outcomes in hypertrophic cardiomyopathy
22. Prognostic implications of NYHA class and NT-proBNP levels in mild heart failure: a PARADIGM-HF analysis
23. Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction
24. Influence of glycaemic status on the risk of cardiovascular events after a myocardial infarction
25. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
26. Systematic review with meta‐analysis: breastfeeding and the risk of Crohnʼs disease and ulcerative colitis
27. Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
28. Deep Learning-Based Automated Workflow for the Interpretation of the Echocardiogram for the Presence of LV Dysfunction and Probability of Pulmonary Hypertension
29. Supplement to: Estimating the long-term treatment benefits of sacubitril-valsartan.
30. Supplement to: Lixisenatide in patients with type 2 diabetes and acute coronary syndrome.
31. Augmented Cross-Sectional Studies with Abbreviated Follow-up for Estimating HIV Incidence
32. Sex Disaggregated Analysis of Risk Factors for Adverse Outcomes in Hypertrophic Cardiomyopathy
33. Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial
34. Lung ultrasound in acute heart failure: association between quality of life, symptoms and B-lines
35. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
36. Zero times one equals two – conceptual problems in placebo research
37. Thyroid dysfunction and incident heart failure phenotypes among older adults: the atherosclerosis risk in communities (aric) study
38. The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems
39. P6350Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the spironolactone for heart failure with preserved ejection fraction (TOPCAT) trial
40. 4301Diastolic dysfunction is an independent predictor of adverse events in patients with systolic dysfunction. Insights from the MADIT-CRT trial
41. P3438Malaria infection and risk of incident heart failure: a nationwide cohort study
42. 4302Machine-learning integration of complex echocardiographic patterns and clinical parameters from cohorts and trials
43. P2258Pulse wave velocity, total arterial compliance, and cardiac structure and function in late life
44. 1347The flu vaccine and mortality in hypertension. A Danish nationwide cohort study
45. Machine-learning analysis of myocardial deformation patterns to predict incident heart failure or death in the general population
46. 1105Machine-learning analysis of myocardial deformation patterns to predict incident heart failure or death in the general population
47. P5419Influence of HIV infection on cardiac structure and function in the era of HAART: a systematic review and meta-analysis of case-control studies
48. P6508Balance of risk and benefit of spironolactone according to renal function in heart failure patients with preserved ejection fraction
49. P1532Contemporary assessment of left ventricular ejection fraction in older adults: the atherosclerosis risk in communities study
50. Adding a new analytical procedure with clinical interpretation in the tool box of survival analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.